C. R. Farias, L. P. de Souza, and M. Lamy, “The provision of the drug mavenclad (cladribine) for the treatment of multiple sclerosis: legal and sanitary controversies in Brazil”, Rev. Bras. de Dir. Constitucional, vol. 25, pp. 240–256, Nov. 2025, doi: 10.62530/rbdc25p240.